Effects of oxymatrine on experimental hepatic fibrosis and its mechanism in vivo

doi:10.3748/wjg.v11.i2.268

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4071)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

426

HTML

2850

Figures (1-5)

519

Tables (1-1)

276

Sum=4071

Jan 14, 2005 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (36)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Jan 14, 2005; 11(2): 268-271
Published online Jan 14, 2005. doi: 10.3748/wjg.v11.i2.268

Full Size Figure Download Figure

Figure 4 Expression of TIMP-1antigen by immunohistochemical staining. 10×10 A: (Control group): There was only a weak expression of TIMP-1 antigen in individual liver cells and hepatic stellate cells (HSCs); B: (CCl₄ group): The expression of TIMP-1 was detected in cytoplasm of most hepatic cells; C: (CCl₄+OM group): There was a significant decline of the expression of TIMP-1 in CCl₄+OM group, as compared with that in CCl₄ group.

Citation: Shi GF, Li Q. Effects of oxymatrine on experimental hepatic fibrosis and its mechanism in vivo. World J Gastroenterol 2005; 11(2): 268-271
URL: https://www.wjgnet.com/1007-9327/full/v11/i2/268.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i2.268